Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash	$ 290,797	$ 337,664
Cash collateral posted to counterparties	16,979	18,552
Investments in securities, at fair value
Receivable for unsettled sales (including pledged securities of $1,084,149 at September 30, 2022)	1,091,891	0
Derivatives, at fair value	1,087,490	199,073
Accrued interest receivable	31,697	10,570
Prepaid and other	3,093	1,094
Subordinated loan to BUCKLER	105,000	105,000
Total Assets	10,915,258	5,277,307
Liabilities:
Repurchase agreements	8,250,066	3,948,037
Cash collateral posted by counterparties	1,000,407	171,060
Payable for unsettled purchases	682,605	0
Derivatives, at fair value	7,105	10,900
Accrued interest payable- repurchase agreements	20,210	944
Accounts payable and other accrued expenses	10,718	2,727
Total Liabilities	9,971,111	4,133,668
Commitments and contingencies (Note 8)
Stockholders’ Equity:
Common stock, $0.001 par value, 300,000 and 200,000 shares authorized; 132,589 shares and 94,152 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively.	132	94
Additional paid-in capital	3,701,921	3,403,127
Cumulative distributions to stockholders	(1,945,351)	(1,837,955)
Accumulated net loss	(797,947)	(528,607)
Accumulated other comprehensive income (loss)	(14,615)	106,973
Total Stockholders’ Equity	944,147	1,143,639
Total Liabilities and Stockholders’ Equity	10,915,258	5,277,307
Agency Securities
Investments in securities, at fair value
Investment securities	8,014,139	4,406,521
U.S. Treasury Securities
Investments in securities, at fair value
Investment securities	274,172	198,833
Series C Preferred Stock
Stockholders’ Equity:
Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 6,847 shares issued and outstanding ($25.00 per share liquidation preference)	$ 7	$ 7